Authors' Reply to Coste et al.: "Levothyrox® New and Old Formulations: Are they Switchable for Millions of Patients?"

Authors' Reply to Coste et al.: "Levothyrox^® New and Old Formulations: Are they Switchable for Millions of Patients?"

Clin Pharmacokinet. 2019 Jul;58(7):967-968. doi: 10.1007/s40262-019-00780-2.

¹ INTHERES, Université de Toulouse, INRA, ENVT, Toulouse, France.
² Service de Pharmacologie Médicale et Clinique, INSERM, UMR 1027, CIC INSERM 1436, Faculté de Médecine, Centre Hospitalier Universitaire de Toulouse, Université de Toulouse, Toulouse, France.
³ The Royal Veterinary College, University of London, London, UK.
⁴ INTHERES, Université de Toulouse, INRA, ENVT, Toulouse, France. pltoutain@wanadoo.fr.
⁵ The Royal Veterinary College, University of London, London, UK. pltoutain@wanadoo.fr.

No abstract available